Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: A prospective, longitudinal, observational study

Supportive Care in Cancer

Volumn 19, Issue 10, 2011, Pages 1549-1563

  Pirri, Carlo ^a,c   Katris, Paul ^b   Trotter, James ^c   Bayliss, Evan ^c   Bennett, Robert ^a   Drummond, Peter ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b Western Australian Clinical Oncology Group   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Cancer; Chemotherapy; Nausea; Non pharmacological risk factors; Radiotherapy; Surgery; Vomiting

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DOPAMINE RECEPTOR BLOCKING AGENT; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; SEROTONIN 3 ANTAGONIST;

AGED; ANTICIPATORY NAUSEA AND VOMITING; ARTICLE; AUSTRALIA; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; EMOTION; FEMALE; HEALTH INSURANCE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AUSTRALIA; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; TIME FACTORS; VOMITING; VOMITING, ANTICIPATORY; YOUNG ADULT;

EID: 80052448892     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0982-y     Document Type: Article

References (50)

1. AS Coates S Abraham SB Kaye T Sowerbutts C Frewin RM Fox MH Tattersall 1983 On the receiving end-patient perception of the side-effects of cancer chemotherapy Eur J Cancer Clin Oncol 19 203 208 6681766 10.1016/0277-5379(83) 90418-2 1:STN:280:DyaL3s7jtFyitw%3D%3D (Pubitemid 13155858)
2. J Richardson G Marks A Levine 1988 The influence of symptoms of disease and side effects on treatment compliance with cancer therapy J Clin Oncol 5 1746 1752 (Pubitemid 19089055)
3. AM Griffin PN Butow AS Coates AM Childs PM Ellis SM Dunn MH Tattersall 1996 On the receiving end. V: patient perceptions of the side-effects of cancer chemotherapy in 1993 Ann Oncol 7 2 189 195 8777177 1:STN:280: DyaK283mt1ejtw%3D%3D (Pubitemid 26094884)
4. JT Hickok JA Roscoe GR Morrow DK King JN Atkins TR Fitch 2003 Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community Cancer 97 2880 2886 12767103 10.1002/cncr.11408 1:CAS:528:DC%2BD3sXkslWrsLg%3D (Pubitemid 36605158)
5. M Watson L Meyer A Thomson S Osofsky 1998 Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy Eur J Cancer 34 831 837 9797694 10.1016/S0959-8049(97)10146-0 1:STN:280: DyaK1M%2FhsVChug%3D%3D (Pubitemid 28248493)
6. JT Hickok JA Roscoe GR Morrow RM Stern B Yang PJ Flynn HE Hynes JJ Kirshner RJ Rosenbluth 1999 Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings Cancer 86 64 71 10391565 10.1002/(SICI)1097- 0142(19990701)86:1<64::AID-CNCR11>3.0.CO;2-# 1:CAS:528:DyaK1MXktleqtLY%3D (Pubitemid 29293378)
7. The Italian Group for Antiemetic Research in Radiotherapy (IGARR) 1999 Radiation-induced emesis: a prospective observational multicenter Italian trial Int Radiat Oncol Biol Phys 44 619 625 10.1016/S0360-3016(99)00055-3 (Pubitemid 29258437)
8. P Kirkbride A Bezjak J Pater B Zee MJ Palmer R Wong P Cross S Gulavita P Blood A Sun G Dundas PK Ganguly J Lim AD Chowdhury SE Kumar AR Dar 2000 Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trial Group phase III study J Clin Oncol 18 1960 1966 10784638 1:CAS:528:DC%2BD3cXjvVentrk%3D (Pubitemid 30261935)
9. R Lanciano DM Sherman J Michalski AJ Preston K Yocom C Friedman 2001 The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy Cancer Investig 9 763 772 10.1081/CNV-100107736 (Pubitemid 33151205)
10. SP Chawla SM Grunberg RJ Gralla PJ Hesketh C Rittenberg ME Elmer C Schmidt A Taylor AD Carides JK Evans KJ Horgan 2003 Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting Cancer 97 9 2290 2300 12712486 10.1002/cncr.11320 1:CAS:528:DC%2BD3sXjvVSjsL8%3D (Pubitemid 36444075)
11. N Neymark R Crott 2005 Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials Support Care Cancer 160 812 818 10.1007/s00520-005-0803-x (Pubitemid 41414022)
12. B Bloechl-Daum RR Deuson P Mavros M Hansen J Herrstedt 2006 Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment J Clin Oncol 24 27 4472 4478 16983116 10.1200/JCO.2006.05.6382 1:CAS:528:DC%2BD28XhtVyisrrL (Pubitemid 46630986)
13. E Ballatori F Roila B Ruggeri S Porrozzi M Iannopollo G Soru G Cruciani B Daniele MC Locatelli J Pellissier R Deuson 2007 The cost of chemotherapy-induced nausea and vomiting in Italy Support Care Cancer 15 1 31 38 16788840 10.1007/s00520-006-0094-x (Pubitemid 46088311)
14. L Cohen CA de Moor P Eisenberg EE Ming H Hu 2007 Chemotherapy-induced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings Support Care Cancer 15 5 497 503 17103197 10.1007/s00520-006-0173-z (Pubitemid 46570778)
15. E Ballatori F Roila B Ruggeri M Betti S Sarti G Soru G Cruciani M Di Maio B Andrea RR Deuson 2007 The impact of chemotherapy-induced nausea and vomiting on health-related quality of life Support Care Cancer 15 179 185 16941136 10.1007/s00520-006-0109-7 (Pubitemid 46332920)
16. Y Tina Shih Y Xu LS Elting 2007 Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy Cancer 110 3 678 685 17567835 10.1002/cncr.22823 (Pubitemid 47106159)
17. K Abbrederis S Lorenzen N Rothling A Ihbe-Heffinger T Schuster C Peschel F Lordick 2009 Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant Onkologie 32 1-2 30 34 19209016 10.1159/000183735 1:CAS:528:DC%2BD1MXhslyhs7c%3D
18. D Osoba B Zee J Pater D Warr J Latreille L Kaizer 1997 Determinants of postchemotherapy nausea and vomiting in patients with cancer J Clin Oncol 15 1 116 123 8996132 1:STN:280:DyaK2s7kvFehtg%3D%3D (Pubitemid 27020564)
19. HJ Lee JY Kwon SW Shin CH Kim SH Baek SW Baik HK Kim KH Kim 2008 Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients Eur J Anaesthesiol 25 9 756 762 18426627 10.1017/S0265021508004262 1:CAS:528:DC%2BD1cXhtFegu7rI
20. A Enblom BB Axelsson G Steineck M Hammar S Börjeson 2009 One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient Support Care Cancer 17 23 32 18528717 10.1007/s00520-008-0445-x
21. Multinational Association of Supportive Care in Cancer (MASCC) (2008). Antiemetic guidelines (latest update: March 2008)-based on the consensus conference on antiemetic therapy. http://www.mascc.org/content/127.html. Accessed 14 Jan 2009
22. MG Kris PJ Hesketh MR Somerfield P Feyer R Clark-Snow JM Koeller GR Morrow LW Chinnery MJ Chesney RJ Gralla SM Grunberg 2006 American Society of Clinical Oncology (ASCO) guideline for antiemetics in oncology: update 2006 Support Care Cancer 13 80 84
23. National Comprehensive Cancer Network (NCCN) (2009). NCCN clinical practice guidelines in oncology: antiemesis V.2.2009. http://www.nccn.org/ professionals/physician-gls/pdf/antiemesis.pdf. Accessed 14 Jan 2009
24. GR Morrow 1992 Behavioural factors influencing the development and expression of chemotherapy induced side effects Br J Cancer 66 SUPPL. XIX S54 S61
25. A Molassiotis MP Saunders J Valle G Wilson P Lorigan A Wardley E Levine R Cowan J Loncaster C Rittenberg 2008 A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre Support Care Cancer 16 201 208 17926070 10.1007/s00520-007-0343-7 1:STN:280:DC%2BD1c%2FkslCjtA%3D%3D
26. SM Grunberg RR Deuson P Mavros O Geling M Hansen G Cruciani B Daniele G De Pouvourville EB Rubenstein G Daugaard 2004 Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: perception versus reality Cancer 100 2261 2268 15139073 10.1002/cncr.20230 (Pubitemid 38580348)
27. CM Booth M Clemons G Dranitsaris A Joy S Young W Callaghan M Trudeau T Petrella 2007 Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study J Support Oncol 5 374 380 17944146 (Pubitemid 47559694)
28. A Molassiotis BMC Yam H Yung FYC Chan TSK Mok 2002 Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients Support Care Cancer 10 139 145 11862503 10.1007/s00520-001-0321-4 1:STN:280:DC%2BD387psFeisA%3D%3D (Pubitemid 36056310)
29. PJ Hesketh 1999 Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice Oncologist 4 191 196 10394587 1:STN:280:DyaK1Mzit1yqsw%3D%3D (Pubitemid 29297482)
30. M Tonato R Clark-Snow D Osoba A Del Favero E Ballatori S Borjeson 2005 Emesis induced by low or minimal emetic risk chemotherapy Support Care Cancer 13 109 111 15714358 10.1007/s00520-004-0703-5 (Pubitemid 40558166)
31. NK Aaronson S Ahmedzai B Bergman M Bullinger A Cull NJ Duez A Filiberti H Flechtner SB Fleishman JC de Haes, et al. 1993 The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 365 376 8433390 10.1093/jnci/85.5.365 1:STN:280:DyaK3s7msVarsQ%3D%3D (Pubitemid 23073154)
32. GL Ringdal K Ringdal 1993 Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses Qual Life Res 2 129 140 8518767 10.1007/BF00435732 1:STN:280:DyaK3s3pvFChuw%3D%3D (Pubitemid 23135397)
33. PJ Selby JAW Chapman J Etazadi-Amoli NF Boyd 1984 The development of a method for assessing quality of life of cancer patients Br J Cancer 50 13 22 6743512 10.1038/bjc.1984.134 1:STN:280:DyaL2c3lsleqsg%3D%3D (Pubitemid 14092641)
34. AT Beck RW Beck 1972 Screening depressed patients in family practice: a rapid technic Postgrad Med 52 81 85 4635613 1:STN:280:DyaE3s%2Fks12gtA%3D%3D
35. M Horowitz N Wilner W Alvarez 1979 Impact of event scale: a measure of subjective stress Psychosom Med 41 209 18 472086 1:STN:280:DyaE1M3kslGjug%3D%3D (Pubitemid 9219271)
36. Eysenck HJ, Eysenck SBG (1991) Manual of the Eysenck Personality Questionnaire (revised). Hodder, London
37. Threlfall TJ, Thompson JR (2000) Cancer incidence and mortality in Western Australia, 1998: a report of the Western Australian Cancer Registry. Health Department of Western Australia, Perth, Australia
38. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) 1998 Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia consensus conference Ann Oncol 9 811 819 10.1023/A:1008471812316 (Pubitemid 28440438)
39. G Guyatt S Walters G Norman 1987 Measuring change over time: assessing the usefulness of evaluative instruments J Chronic Dis 40 171 178 3818871 10.1016/0021-9681(87)90069-5 1:STN:280:DyaL2s7jvVWitw%3D%3D (Pubitemid 17007065)
40. F Roila D Donati S Tamberi G Margutti 2002 Delayed emesis: incidence, pattern, prognostic factors and optimal treatment Support Care Cancer 10 88 95 11862498 10.1007/s005200100295 (Pubitemid 36056305)
41. GR Morrow J Lindke PM Black 1991 Anticipatory nausea development in cancer patients: replication and extension of a learning model Br J Psychol 82 61 72 2029605 10.1111/j.2044-8295.1991.tb02382.x
42. DH Bovbjerg 2006 The continuing problem of post chemotherapy nausea and vomiting: contributions of classical conditioning Auton Neurosci 129 1-2 92 98 16905371 10.1016/j.autneu.2006.07.016 (Pubitemid 44470867)
43. J Foubert G Vaessen 2005 Nausea: the neglected symptom? Eur J Oncol Nurs 9 21 32 15774338 10.1016/j.ejon.2004.03.006 (Pubitemid 40361583)
44. J Pater J Slamet B Zee D Osoba D Warr J Rusthoven 1994 Inconsistency of prognostic factors for postchemotherapy nausea and vomiting Support Care Cancer 2 161 166 8032701 10.1007/BF00417474 1:STN:280:DyaK2czgsF2htg%3D%3D
45. Australian Institute of Health and Welfare (AIHW) (2009) Australian health statistics 2007-08. AIHW, Canberra, Australia
46. National Breast Cancer Centre (NBCC) and National Cancer Control Initiative (NCCI) (2003) Clinical practice guidelines for the psychosocial care of adults with cancer. NBCC, Camperdown, Australia
47. JL Harousseau R Zittoun J Bonneterre M Hedouin J Ouvry 2000 Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination Bull Cancer 87 6 491 497 10903790 1:STN:280:DC%2BD3czmsVSrtQ%3D%3D (Pubitemid 30462856)
48. JM Ezzo MA Richardson A Vickers C Allen SL Dibble BF Issell L Lao M Pearl G Ramirez JA Roscoe J Shen JC Shivnan K Streitberger I Treish G Zhang 2006 Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting (review) Cochrane Database Syst Rev 2 1 33
49. K Luebbert B Dahme M Hasenbring 2001 The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review Psychooncology 10 6 490 502 11747061 10.1002/pon.537 1:STN:280: DC%2BD3Mnps1Gjtg%3D%3D (Pubitemid 33081035)
50. DG Warr PJ Hesketh RJ Gralla HB Muss J Herrstedt PD Eisenberg H Raftopoulos SM Grunberg M Gabriel A Rodgers N Bohidar G Klinger CM Hustad KJ Horgan F Skobieranda 2005 Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy J Clin Oncol 23 2822 2830 15837996 10.1200/JCO.2005.09.050 1:CAS:528:DC%2BD2MXktleqt74%3D (Pubitemid 46179473)